Halbert Hargrove Global Advisors, LLC Pfizer Inc Transaction History

Halbert Hargrove Global Advisors, LLC

$1.72 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $27,415 - $35,690	-696 Reduced 6.15%	10,629 $433,000
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $7,556 - $9,864	-181 Reduced 1.57%	11,325 $0
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $10,152 - $12,393	-232 Reduced 1.98%	11,506 $504,000
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $27,964 - $33,157	-601 Reduced 4.87%	11,738 $615,000
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $256,566 - $317,917	-5,608 Reduced 31.25%	12,339 $639,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $44,832 - $66,456	1,085 Added 6.43%	17,947 $1.06 Million
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $9,969 - $12,806	254 Added 1.53%	16,862 $725,000
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $2,836 - $3,213	79 Added 0.48%	16,608 $650,000
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $4,822 - $5,438	144 Added 0.88%	16,529 $598,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $330,382 - $420,109	9,871 Added 151.54%	16,385 $604,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $13,271 - $15,570	418 Added 6.86%	6,514 $240,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $22,770 - $27,624	-756 Reduced 11.03%	6,096 $200,000
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $47,275 - $67,546	-1,749 Reduced 20.33%	6,852 $224,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $7,505 - $8,518	-228 Reduced 2.58%	8,601 $337,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $4,418 - $5,729	136 Added 1.56%	8,829 $317,000
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $321,467 - $360,933	8,693 New	8,693 $377,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $290,737 - $319,423	-7,753 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $7,809 - $8,903	-203 Reduced 2.55%	7,753 $338,000
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $12,478 - $15,135	-362 Reduced 4.35%	7,956 $351,000
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $263 - $281	8 Added 0.1%	8,318 $302,000
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $19,401 - $22,508	608 Added 7.89%	8,310 $295,000
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $11,208 - $11,892	-337 Reduced 4.19%	7,702 $279,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $249,209 - $274,531	8,039	8,039 $287,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account